scholarly journals Cold protection allows local cryotherapy in a clinical-relevant model of traumatic optic neuropathy

2021 ◽  
Author(s):  
Yikui Zhang ◽  
Mengyun Li ◽  
Bo Yu ◽  
Shengjian Lu ◽  
Lujie Zhang ◽  
...  

Therapeutic hypothermia (TH) is potentially an important therapy for central nervous system (CNS) trauma. However, its clinical application remains controversial, hampered by two major factors: 1) Many of the CNS injury sites, such as the optic nerve (ON), are deeply buried, preventing access for local TH. The alternative is to apply TH systemically, which significantly limits the applicable temperature range. 2) Even with possible access for "local refrigeration", cold-induced cellular damage offsets the benefit of TH. Here we present a clinically translatable model of traumatic optic neuropathy (TON) by applying clinical trans-nasal endoscopic surgery to goats and non-human primates. This model faithfully recapitulates clinical features of TON such as the injury site (pre-chiasmatic ON), the spatiotemporal pattern of neural degeneration, and the accessibility of local treatments with large operating space. We also developed a computer program to simplify the endoscopic procedure and expand this model to other large animal species. Moreover, applying a cold-protective treatment, inspired by our previous hibernation research, enables us to deliver deep hypothermia (4°C) locally to mitigate inflammation and metabolic stress (indicated by the transcriptomic changes after injury) without cold-induced cellular damage, and confers prominent neuroprotection both structurally and functionally. Intriguingly, neither treatment alone was effective, demonstrating that in situ deep hypothermia combined with hibernation-mimicking cold protection constitutes a breakthrough for TH as a therapy for TON and other CNS traumas.

Skull Base ◽  
2009 ◽  
Vol 19 (01) ◽  
Author(s):  
Francesca Simoncello ◽  
Paolo Castelnuovo ◽  
Maurizio Bignami ◽  
Cristhian Cambria ◽  
Giovanni Delù ◽  
...  

2019 ◽  
Vol 11 (2) ◽  
pp. 51-52
Author(s):  
G Thiruvengada Senthil Kumar ◽  
◽  
L Feroz Ahamed ◽  

2019 ◽  
Vol 11 (2) ◽  
pp. 46-47
Author(s):  
Thiruvengada Senthil kumar ◽  
◽  
L Feroz Ahamed ◽  

2019 ◽  
Vol 11 (2) ◽  
pp. 40-41
Author(s):  
G Thiruvengada Senthil Kumar ◽  
◽  
L Feroz Ahamed ◽  

2003 ◽  
Vol 38 (4) ◽  
pp. 289-292 ◽  
Author(s):  
Michelle L. Young ◽  
Khalid Sabti ◽  
Michael A. Kapusta

Stresses ◽  
2021 ◽  
Vol 1 (1) ◽  
pp. 30-47
Author(s):  
Maria Mortoglou ◽  
David Wallace ◽  
Aleksandra Buha Buha Djordjevic ◽  
Vladimir Djordjevic ◽  
E. Damla Arisan ◽  
...  

Pancreatic ductal adenocarcinoma (PDAC) is the most aggressive and invasive type of pancreatic cancer (PCa) and is expected to be the second most common cause of cancer-associated deaths. The high mortality rate is due to the asymptomatic progression of the clinical features until the advanced stages of the disease and the limited effectiveness of the current therapeutics. Aberrant expression of several microRNAs (miRs/miRNAs) has been related to PDAC progression and thus they could be potential early diagnostic, prognostic, and/or therapeutic predictors for PDAC. miRs are small (18 to 24 nucleotides long) non-coding RNAs, which regulate the expression of key genes by targeting their 3′-untranslated mRNA region. Increased evidence has also suggested that the chemoresistance of PDAC cells is associated with metabolic alterations. Metabolic stress and the dysfunctionality of systems to compensate for the altered metabolic status of PDAC cells is the foundation for cellular damage. Current data have implicated multiple systems as hallmarks of PDAC development, such as glutamine redox imbalance, oxidative stress, and mitochondrial dysfunction. Hence, both the aberrant expression of miRs and dysregulation in metabolism can have unfavorable effects in several biological processes, such as apoptosis, cell proliferation, growth, survival, stress response, angiogenesis, chemoresistance, invasion, and migration. Therefore, due to these dismal statistics, it is crucial to develop beneficial therapeutic strategies based on an improved understanding of the biology of both miRs and metabolic mediators. This review focuses on miR-mediated pathways and therapeutic resistance mechanisms in PDAC and evaluates the impact of metabolic alterations in the progression of PDAC.


2021 ◽  
Vol 10 (1) ◽  
pp. 8
Author(s):  
Reas S. Khan ◽  
Ahmara G. Ross ◽  
Puya Aravand ◽  
Kimberly Dine ◽  
Evan B. Selzer ◽  
...  

2014 ◽  
Vol 41 (4) ◽  
pp. 432 ◽  
Author(s):  
Jung Ho Lee ◽  
Yoon-Jae Lee ◽  
Sue Min Kim ◽  
Young-Joon Jun ◽  
Young-Jin Kim

Sign in / Sign up

Export Citation Format

Share Document